scispace - formally typeset
Journal ArticleDOI

Novel therapies for childhood cancer and impact on puberty

Reads0
Chats0
TLDR
Recognising reduced endocrine sequelae to lower intensity treatments and potential future toxicities of new treatments are both key for future long-term follow up strategies.
About
This article is published in Current Opinion in Endocrine and Metabolic Research.The article was published on 2020-10-01. It has received 3 citations till now. The article focuses on the topics: Cancer.

read more

Citations
More filters

Gonadal and Sexual Dysfunction in Childhood Cancer Survivors

TL;DR: The childhood cancer survivors in this study showed a high prevalence of gonadal/sexual dysfunction; accordingly, proper strategies are needed to manage these complications.
Journal ArticleDOI

Childhood Cancer

TL;DR:
References
More filters
Journal ArticleDOI

Survivors of childhood and adolescent cancer: life-long risks and responsibilities

TL;DR: The burden of responsibility to understand the long-term morbidity and mortality that is associated with currently successful treatments must be borne by many, including the research and health care communities, survivor advocacy groups, and governmental and policy-making entities.
Journal ArticleDOI

Cancer immunotherapy - immune checkpoint blockade and associated endocrinopathies.

TL;DR: The current data regarding immune-related endocrinopathies, including hypophysitis, thyroid dysfunction and diabetes mellitus are described and the clinical management of these endocrineopathies is discussed within the context of the current understanding of the mechanisms of IRAEs.
Journal ArticleDOI

Ovarian Failure and Reproductive Outcomes After Childhood Cancer Treatment: Results From the Childhood Cancer Survivor Study

TL;DR: These studies demonstrated that women treated with pelvic irradiation and/or increasing alkylating agent doses were at risk for acute ovarian failure, premature menopause, and small-for-gestational-age offspring.
Journal ArticleDOI

Survivors of Childhood Cancer in the United States: Prevalence and Burden of Morbidity

TL;DR: The Estimated prevalence of survivors of childhood cancer is increasing, as is the estimated prevalence of morbidity in those ≥5 years after diagnosis, and efforts to understand how to effectively decrease morbidity burden and incorporate effective care coordination and rehabilitation models to optimize longevity and well-being in this population should be a priority.
Journal ArticleDOI

Endocrine side effects induced by immune checkpoint inhibitors

TL;DR: Hypophysitis has emerged as a distinctive side effect of CTLA4-blocking antibodies, establishing a new form of autoimmune pituitary disease in patients affected by advanced cutaneous melanoma.